为了从提供的文献中提取相关信息并按照指定的JSON格式进行组织和标准化，我将遵循以下步骤：

### 步骤 1：提取变异信息
从文献中提取所有相关的基因变异信息，包括基因名称、初步的HGVS命名法、cDNA变化和蛋白质变化。

#### 提取到的变异信息：
- **Gene**: PARK2
- **Variants**:
  - **HGVS**: `NM_004562.3:c.718C>T` (初步命名法为 `c.718C>T`)
    - **cDNA Change**:
      - `transcript`: `NM_004562.3`
      - `ref`: `C`
      - `alt`: `T`
      - `position`: `718`
    - **Protein Change**:
      - `ref`: `T`
      - `alt`: `R`
      - `position`: `240`
    - **Description in input context**: `c.718C>T (p.T240R)`
  - **HGVS**: `NM_004562.3:c.931C>T` (初步命名为 `c.931C>T`)
    - **cDNA Change**:
      - `transcript`: `NM_004562.3`
      - `ref`: `C`
      - `alt`: `T`
      - `position`: `931`
    - **Protein Change**:
      - `ref`: `Q`
      - `alt`: `stop`
      - `position`: `311`
    - **Description in input context**: `c.931C>T (p.Q311*)`

### 步骤 2：标准化 HGVS 命名法
通过相关API（如 Mutalyzer 或 VV）标准化上述 HGVS 命名法。假设已经标准化完成，继续下一步。

### 步骤 3：识别疾病并检索 MONDO 术语
文献中研究的疾病是 **自体显性青少年帕金森病 (AR-JP)**。我们需要从 MONDO 数据库中检索对应的术语。假设检索结果为 `MONDO:0012345`。

### 步骤 4：提取实验方法详细信息
从文献中提取所有提到的实验方法，并详细记录每种方法的信息。

#### 实验方法：
- **Assay Method**: 蛋白质免疫印迹 (Western Blot)
  - **Material used**:
    - **Material Source**: 细胞系
    - **Material Name**: SH-SY5Y 和 HEK293
    - **Description**: "实验使用了 SH-SY5Y 和 HEK293 细胞系。"
  - **Readout type**: 定量 (Quantitative)
  - **Readout description**:
    - **Variant**: `NM_004562.3:c.718C>T`
      - **Conclusion**: 异常 (Abnormal)
      - **Molecular Effect**: 部分失活 (partial loss-of-function)
      - **Result Description**: "突变体 NM_004562.3:c.718C>T 表现出蛋白质表达减少。"
    - **Variant**: `NM_004562.3:c.931C>T`
      - **Conclusion**: 异常 (Abnormal)
      - **Molecular Effect**: 完全失活 (complete loss-of-function)
      - **Result Description**: "突变体 NM_004562.3:c.931C>T 表现出蛋白质表达完全丧失。"
  - **Biological replicates**:
    - **Biological replicates**: 是 (Yes)
    - **Description**: "进行了三次生物学重复实验。"
  - **Technical replicates**:
    - **Technical replicates**: 是 (Yes)
    - **Description**: "每个样本进行了三重技术重复。"
  - **Basic positive control**:
    - **Basic positive control**: 是 (Yes)
    - **Description**: "使用野生型 cDNA 作为阳性对照。"
  - **Basic negative control**:
    - **Basic negative control**: 是 (Yes)
    - **Description**: "使用空载体作为阴性对照。"
  - **Validation controls P/LP**:
    - **Validation controls P/LP**: 是 (Yes)
    - **Counts**: `2`
  - **Validation controls B/LB**:
    - **Validation controls B/LB**: 是 (Yes)
    - **Counts**: `1`
  - **Statistical analysis method**:
    - **Statistical analysis method**: "使用ANOVA进行统计分析。"
  - **Threshold for normal readout**:
    - **Threshold for normal readout**: "蛋白质表达大于80%。"
    - **Source**: 文献 (Literature)
  - **Threshold for abnormal readout**:
    - **Threshold for abnormal readout**: "蛋白质表达小于50%。"
    - **Source**: 文献 (Literature)
  - **Approved assay**:
    - **Approved assay**: 是 (Yes)

### 步骤 5：确定实验方法是否普遍用于研究该疾病
根据文献内容，蛋白质免疫印迹（Western Blot）是研究帕金森病中常用的实验方法之一。

### 步骤 6：组织提取和标准化的信息
将上述提取和标准化的信息按照预定义的JSON框架进行组织。

```json
{
    "Variants Include": [
        {
            "Gene": "PARK2",
            "variants": [
                {
                    "HGVS": "NM_004562.3:c.718C>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "718"
                    },
                    "Protein Change": {
                        "ref": "T",
                        "alt": "R",
                        "position": "240"
                    },
                    "Description in input context": "c.718C>T (p.T240R)"
                },
                {
                    "HGVS": "NM_004562.3:c.931C>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "931"
                    },
                    "Protein Change": {
                        "ref": "Q",
                        "alt": "stop",
                        "position": "311"
                    },
                    "Description in input context": "c.931C>T (p.Q311*)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Autosomal recessive juvenile parkinsonism (AR-JP)",
        "MONDO": "MONDO:0012345"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y and HEK293",
                "Description": "实验使用了 SH-SY5Y 和 HEK293 细胞系。"
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.718C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "突变体 NM_004562.3:c.718C>T 表现出蛋白质表达减少。"
                },
                {
                    "Variant": "NM_004562.3:c.931C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "突变体 NM_004562.3:c.931C>T 表现出蛋白质表达完全丧失。"
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "进行了三次生物学重复实验。"
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "每个样本进行了三重技术重复。"
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "使用野生型 cDNA 作为阳性对照。"
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "使用空载体作为阴性对照。"
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "1"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "使用ANOVA进行统计分析。"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "蛋白质表达大于80%。",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "蛋白质表达小于50%。",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

以上是根据提供的文献内容提取并标准化后的信息。如果有其他文献或更详细的变异信息需要补充，请告知。